Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/1b/3a/7a/1b3a7a48-70b3-cb49-ae64-8221b0fa7623/mza_13362227464609804571.jpg/600x600bb.jpg
iMedicus Diabetes
imedicusdiabetes
14 episodes
7 months ago
Show more...
Medicine
Health & Fitness
RSS
All content for iMedicus Diabetes is the property of imedicusdiabetes and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Show more...
Medicine
Health & Fitness
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/1b/3a/7a/1b3a7a48-70b3-cb49-ae64-8221b0fa7623/mza_13362227464609804571.jpg/600x600bb.jpg
Diabetes Update Podcast Series: Let’s Be Friends: A Collaborative Conversation Between Endocrinology and Cardiology - Alice Cheng, MD; Anil Gupta, MD
iMedicus Diabetes
11 minutes 26 seconds
3 years ago
Diabetes Update Podcast Series: Let’s Be Friends: A Collaborative Conversation Between Endocrinology and Cardiology - Alice Cheng, MD; Anil Gupta, MD
On this episode of the Diabetes Update 2022 podcast series titled ‘Let’s Be Friends: a collaborative conversation between endocrinology and cardiology’, we are pleased to welcome Dr. Alice Cheng, an endocrinologist, and Associate Professor in the Department of Medicine at the University of Toronto. She is accompanied by Dr Anil Gupta, cardiologist and medical director at the CCU and Clinical Cardiology Trillium Health partner. He is also a partner at the Mississauga Clinical Research Centre. In this conversation, our guests discuss the different perspectives and considerations endocrinologists and cardiologists have when starting on antihyperglycemic therapy.  How do cardiology and endocrinology work together? Where do the lines blur with shared patient care and how can we better communicate with each other to improve patient outcomes? This program was made possible through funding from Boehringer-Ingelheim and Eli Lilly
iMedicus Diabetes